<DOC>
	<DOC>NCT02351089</DOC>
	<brief_summary>The aim of the current Project is to study the efficacy of a probiotic Product in reducing the symptoms of gastrointestinal toxicity linked to the irradiation of gynecologic cancer.</brief_summary>
	<brief_title>Probiotics in Radiation-treated Gynecologic Cancer</brief_title>
	<detailed_description />
	<criteria>Women diagnosed with cancer in the small pelvis and waiting to receive radiotherapy either as a primary or as a secondary treatment following surgery. Chemotherapy may or may not be part of the treatment regimen. Age, older than 18 years old. Agreement for participation in the study by signed written informed consent. Previously treated with irradiation of the pelvic area. Reluctance to refrain from using other probiotic products during the participation in the study.</criteria>
	<gender>Female</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>November 2016</verification_date>
</DOC>